These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6263222)

  • 21. Motor nerve dysfunction in delayed DFP neuropathy.
    Lowndes HE; Baker T; Riker WF
    Eur J Pharmacol; 1974 Nov; 29(1):66-73. PubMed ID: 4435046
    [No Abstract]   [Full Text] [Related]  

  • 22. Possible involvement of a neurotrophic factor during the early stages of organophosphate-induced delayed neurotoxicity.
    Pope C; diLorenzo K; Ehrich M
    Toxicol Lett; 1995 Jan; 75(1-3):111-7. PubMed ID: 7863517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy.
    Milatovic D; Moretto A; Osman KA; Lotti M
    Chem Res Toxicol; 1997 Sep; 10(9):1045-8. PubMed ID: 9305588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of prevention and potentiation of diisopropyl phosphorofluoridate (DFP)-induced delayed neurotoxicity on the mRNA expression of neurofilament subunits in hen central nervous system.
    Xie K; Gupta RP; Abou-Donia MB
    Biochem Cell Biol; 2001; 79(2):207-17. PubMed ID: 11310568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):125-31. PubMed ID: 322257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the inhibitory action of DFP and PMSF on histamine release from isolated rat mast cells [proceedings].
    Diamant B; Patkar SA
    Agents Actions; 1977 Mar; 7(1):110-1. PubMed ID: 67779
    [No Abstract]   [Full Text] [Related]  

  • 27. Protein levels of neurofilament subunits in the hen central nervous system following prevention and potentiation of diisopropyl phosphorofluoridate (DFP)-induced delayed neurotoxicity(1).
    Xie K; Gupta RP; Abou-Donia MB
    Biochem Pharmacol; 2002 Jan; 63(1):11-9. PubMed ID: 11754869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration in cytoskeletal protein levels in sciatic nerve on post-treatment of diisopropyl phosphorofluoridate (DFP)-treated hen with phenylmethylsulfonyl fluoride.
    Xie K; Gupta RP; Abou-Donia MB
    Neurochem Res; 2001 Mar; 26(3):235-43. PubMed ID: 11495547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathological assessment of triphenyl phosphite neurotoxicity in the hen.
    Carrington CD; Brown HR; Abou-Donia MB
    Neurotoxicology; 1988; 9(2):223-33. PubMed ID: 3205432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfonyl fluorides and the promotion of diisopropyl fluorophosphate neuropathy.
    Osman KA; Moretto A; Lotti M
    Fundam Appl Toxicol; 1996 Oct; 33(2):294-7. PubMed ID: 8921348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenylmethylsulfonyl fluoride, a potentiator of neuropathy, alters the interaction of organophosphorus compounds with soluble brain esterases.
    Mangas I; Vilanova E; Estévez J
    Chem Res Toxicol; 2012 Nov; 25(11):2393-401. PubMed ID: 23009703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, biochemical, electrophysiologic, and histologic assessment of chlorpyrifos induced delayed neuropathy in the cat.
    Fikes JD; Zachary JF; Parker AJ; Beasley VR
    Neurotoxicology; 1992; 13(3):663-78. PubMed ID: 1282230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of neuropathy inducers and potentiators/promoters with soluble esterases.
    Estévez J; Mangas I; Sogorb MÁ; Vilanova E
    Chem Biol Interact; 2013 Mar; 203(1):245-50. PubMed ID: 23200747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The correlation between the recovery rate of neurotoxic esterase activity and sensitivity to organophosphorus-induced delayed neurotoxicity.
    Carrington CD; Abou-Donia MB
    Toxicol Appl Pharmacol; 1984 Sep; 75(2):350-7. PubMed ID: 6474467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease of phosphofructokinase activity in relation to the pathogenesis of triorthocresyl-phosphate-induced delayed neuropathy.
    Hernández AF; Pla A; Villanueva E
    Rev Esp Fisiol; 1992 Sep; 48(3):139-46. PubMed ID: 1301629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neuropathology of DFP at cat soleus neuromuscular junction.
    Glazer EJ; Baker T; Riker WF
    J Neurocytol; 1978 Dec; 7(6):741-58. PubMed ID: 731281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on drug-induced neuropathies. III. Motor nerve deficit in cats with experimental acrylamide neuropathy.
    Lowndes HE; Baker T
    Eur J Pharmacol; 1976 Jan; 35(1):177-84. PubMed ID: 1253819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effect of the serine protease inhibitor phenyl methyl sulfonyl fluoride on cytochemically detectable esterases in human leucocytes and platelets.
    Dufer J; Trentesaux C; Desplaces A
    Scand J Haematol; 1984 Jan; 32(1):25-32. PubMed ID: 6364322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fine structural changes in cat L7 ventral horn neurones after chronic sub LD50 DFP.
    Sikora-Vanmeter KC; Vanmeter WG; Willetts J; Grieve PA
    Brain Res Bull; 1983 May; 10(5):631-8. PubMed ID: 6871735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of various post-treatment by phenylmethylsulfonyl fluoride on delayed neurotoxicity induced by leptophos.
    Piao FY; Kitabatake M; Xie XK; Yamauchi T
    J Toxicol Sci; 1995 Nov; 20(5):609-17. PubMed ID: 8720167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.